199 related articles for article (PubMed ID: 29730454)
1. Phase solubility studies and anti-Trichomonas vaginalis activity evaluations of metronidazole and methylated β-cyclodextrin complexes: Comparison of CRYSMEB and RAMEB.
Malli S; Bories C; Ponchel G; Loiseau PM; Bouchemal K
Exp Parasitol; 2018 Jun; 189():72-75. PubMed ID: 29730454
[TBL] [Abstract][Full Text] [Related]
2.
Ghosh AP; Aycock C; Schwebke JR
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439963
[TBL] [Abstract][Full Text] [Related]
3. Chlorinated metronidazole as a promising alternative for treating trichomoniasis.
Chacon MO; Fonseca THS; Oliveira SBV; Alacoque MA; Franco LL; Tagliati CA; Cassali GD; Campos-Mota GP; Alves RJ; Capettini LSA; Gomes MA
Parasitol Res; 2018 May; 117(5):1333-1340. PubMed ID: 29502297
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in
Graves KJ; Novak J; Secor WE; Kissinger PJ; Schwebke JR; Muzny CA
Parasitology; 2020 Nov; 147(13):1383-1391. PubMed ID: 32729451
[TBL] [Abstract][Full Text] [Related]
5. Anti-Trichomonas vaginalis activity of 1,10-phenanthroline-5,6-dione-based metallodrugs and synergistic effect with metronidazole.
Vargas Rigo G; Petro-Silveira B; Devereux M; McCann M; Souza Dos Santos AL; Tasca T
Parasitology; 2019 Aug; 146(9):1179-1183. PubMed ID: 30207253
[TBL] [Abstract][Full Text] [Related]
6. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of some medicinal plants on cultured Trichomonas Vaginalis.
Selim MA; Fawzy EM; Abd El-Rahman EM; Abdel Hady RS; Badr MS; Abdel Hamed EF
J Infect Dev Ctries; 2020 Jul; 14(7):793-799. PubMed ID: 32794472
[TBL] [Abstract][Full Text] [Related]
8. Highly Potent 1
Kumar S; Bains T; Won Kim AS; Tam C; Kim J; Cheng LW; Land KM; Debnath A; Kumar V
Front Cell Infect Microbiol; 2018; 8():380. PubMed ID: 30425970
[TBL] [Abstract][Full Text] [Related]
9. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
[TBL] [Abstract][Full Text] [Related]
10. Proteomic signatures of metronidazole-resistant Trichomonas vaginalis reveal novel proteins associated with drug resistance.
Lin HC; Chu LJ; Huang PJ; Cheng WH; Zheng YH; Huang CY; Hong SW; Chen LC; Lin HA; Wang JY; Chen RM; Lin WN; Tang P; Huang KY
Parasit Vectors; 2020 Jun; 13(1):274. PubMed ID: 32487244
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
[TBL] [Abstract][Full Text] [Related]
12. The effect of iron on metronidazole activity against Trichomonas vaginalis in vitro.
Elwakil HS; Tawfik RA; Alam-Eldin YH; Nassar DA
Exp Parasitol; 2017 Nov; 182():34-36. PubMed ID: 28935536
[TBL] [Abstract][Full Text] [Related]
13. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity.
Malla N; Kaul P; Sehgal R; Gupta I
Indian J Med Microbiol; 2011; 29(2):152-7. PubMed ID: 21654110
[TBL] [Abstract][Full Text] [Related]
14. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE
Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348
[TBL] [Abstract][Full Text] [Related]
15. The effect of 3-(biphenyl-4-yl)-3-hydoxyquinuclidine (BPQ-OH) and metronidazole on Trichomonas vaginalis: a comparative study.
Rocha DA; de Andrade Rosa I; Urbina JA; de Souza W; Benchimol M
Parasitol Res; 2014 Jun; 113(6):2185-97. PubMed ID: 24752367
[TBL] [Abstract][Full Text] [Related]
16. High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil.
da Luz Becker D; dos Santos O; Frasson AP; de Vargas Rigo G; Macedo AJ; Tasca T
Infect Genet Evol; 2015 Aug; 34():181-7. PubMed ID: 26160539
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of nitazoxanide against some metronidazole-resistant and susceptible Trichomonas vaginalis isolates.
Abdel-Magied AA; Hammouda MM; Mosbah A; El-Henawy AA
J Infect Chemother; 2017 Apr; 23(4):230-233. PubMed ID: 28131737
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of netropsin dihydrochloride against the viability, cytopathogenicity and hemolytic activity of Trichomonas vaginalis clinical isolates.
Abou Gamra MM; Kamel HH; Ezz Eldin HM; Taha Zahran FM
J Infect Chemother; 2019 Dec; 25(12):955-964. PubMed ID: 31189504
[TBL] [Abstract][Full Text] [Related]
19. Biological variability of Trichomonas vaginalis clinical isolates from symptomatic and asymptomatic patients.
Hussien EM; El-Sayed HZ; Shaban MM; Salm AM; Rashwan M
J Egypt Soc Parasitol; 2004 Dec; 34(3):979-88. PubMed ID: 15587322
[TBL] [Abstract][Full Text] [Related]
20. Comparison of in vitro activity of metronidazole and garlic-based product (Tomex®) on Trichomonas vaginalis.
Ibrahim AN
Parasitol Res; 2013 May; 112(5):2063-7. PubMed ID: 23455944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
